Amgen (AMGN) PT Lowered to $324 at RBC Capital Despite Improved Growth Visibility
Tweet Send to a Friend
RBC Capital analyst Gregory Renza lowered the price target on Amgen (NASDAQ: AMGN) to $324.00 (from $330.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
